IN8bio, Inc. (INAB) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts INAB Hot Sheet
Join SI Premium – FREE
IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- HIVE Digital's BUZZ HPC signs $350M AI cloud deal
- AstraZeneca's Tagrisso and Orpathys combo meets Phase III goals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
